---
schema_version: "secwatch.filing_event.v1"
accession: "0001688757-23-000008"
form_type: "8-K"
ticker: "ESTA"
cik: "0001688757"
company_name: "ESTABLISHMENT LABS HOLDINGS INC."
filed_at: "2023-01-11T23:59:59+00:00"
generated_at: "2026-06-20T16:35:33.160290+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.72
calibrated_materiality_score: 0.72
confidence: "high"
source: SEC EDGAR
---

# Estab. Labs ready to submit PMA Module 4 for Motiva implants in Q1 2023; targets $500M revenue by FY2026

## Summary
- Notified FDA it is ready to submit Module 4 of pre-market approval for Motiva Implants in the U.S.
- Expects to file Module 4 during Q1 2023, working with FDA on optimal timing.
- CEO to present at 41st J.P. Morgan Healthcare Conference on January 12, 2023.
- Company targets $500 million in annual revenue for fiscal year 2026.
- Presentation materials furnished as Exhibit 99.1; forward-looking statements noted.

## SEC filing metadata
- accession: 0001688757-23-000008
- form_type: 8-K
- ticker: ESTA
- cik: 0001688757
- company_name: ESTABLISHMENT LABS HOLDINGS INC.
- filed_at: 2023-01-11T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.72
- calibrated_materiality_score: 0.72
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1688757/000168875723000008/0001688757-23-000008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1688757/000168875723000008/esta-20230111.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001688757-23-000008
- JSON: https://secwatch.observer/filing/0001688757-23-000008.json
- Plain text: https://secwatch.observer/filing/0001688757-23-000008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.